New drug to supercharge immune cells in the fight against cancer

Killer T cells surround a cancer cell. Credit: NIH

A new cancer treatment with the ability to normalise tumour blood vessels and boost the body's immune system has been developed by researchers from The University of Western Australia and the Harry Perkins Institute of Medical Research.

Many tumours can become resistant to the body's immune system by creating a barrier of tangled that feed the tumour while locking out immune cells that would attack cancer cells.

UWA Professor Ruth Ganss, who is also head of the Perkins Cancer and Cell Biology Division, said the new treatment worked by generating more normal blood vessels and lymph-node-like structures within the cancer, which together enabled immune cells to better reach the cancer core.

"Lymph nodes, a vital component of our immune system, normally only exist outside of the cancer and work to filter and generate that fight infection," Professor Ganss said.

"Our drug strengthens the against tumours by inducing these lymph-node-structures together with normalised blood vessels, producing that infiltrate deep into the cancer. There are currently no single treatments available which can produce these two features in cancers.

"Our research shows that once our drug has triggered the lymph-node-structures within the cancer, current immunotherapies that have been approved for clinical use, can work more effectively.

"We've tested our treatment on pancreas and lung cancer models, which are particularly difficult to treat, and have had very promising results.

"We envision that a combination of our drug and existing immunotherapies will greatly enhance the outcomes for patients in the future."

The research was published in the journal Nature Immunology.

Explore further

Worm infection reveals cross-talk in the lymph nodes

More information: Anna Johansson-Percival et al, De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors, Nature Immunology (2017). DOI: 10.1038/ni.3836
Journal information: Nature Immunology

Citation: New drug to supercharge immune cells in the fight against cancer (2017, September 28) retrieved 22 May 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors